Related Experiment Videos
Analysis of gp39/CD40 interactions using molecular models and site-directed mutagenesis
J Bajorath1, J S Marken, N J Chalupny
1Bristol-Myers Squibb Pharmaceutical Research Institute, Seattle, Washington 98121, USA.
Biochemistry
|August 8, 1995
Summary
This study maps the binding sites of gp39 and CD40, crucial for immune responses. Molecular modeling and mutagenesis identified key residues involved in their interaction, similar to TNF-beta/TNFR.
Area of Science:
- Immunology
- Structural Biology
- Molecular Modeling
Background:
- gp39 (CD40L) on T cells interacts with CD40 on antigen-presenting cells, regulating immune responses.
- gp39 and CD40 are homologous to Tumor Necrosis Factor (TNF) and its receptor (TNFR).
- Previous studies used mutagenesis guided by TNF-beta/TNFR structure to identify gp39/CD40 interaction residues.
Purpose of the Study:
- To create molecular models of gp39 and CD40 using the TNF-beta/TNFR crystal structure.
- To extend mutagenesis analysis of gp39/CD40 interactions using these models.
- To delineate the binding sites and interaction mechanism between gp39 and CD40.
Main Methods:
- Utilized the TNF-beta/TNFR complex crystal structure as a template for molecular modeling.
- Performed site-directed mutagenesis on gp39 and CD40 residues.
- Analyzed interaction interfaces and mapped binding sites.
Main Results:
- Identified additional gp39 residues (Y146, R203, Q220) and CD40 residues (E74, E117) involved in binding.
- Confirmed the importance of gp39 Y145 and CD40 Y82 residues.
- Outlined approximate binding sites on gp39 and CD40, involving multiple residue clusters and adjacent gp39 monomers.
Conclusions:
- The gp39/CD40 interaction mechanism is structurally similar to the TNF-beta/TNFR system.
- Detailed mapping of binding sites provides insights into immune regulation.
- Molecular models serve as valuable tools for further mutagenesis studies.